November 1, 2018 / 11:08 AM / 20 days ago

Teva Pharm Q3 profit tops estimates, raises 2018 profit forecast

TEL AVIV, Nov 1 (Reuters) - Israel's heavily indebted Teva Pharmaceutical Industries reported a smaller-than-expected drop in third-quarter profit on Thursday and raised its earnings outlook for 2018.

The world's largest generic drugmaker earned 68 cents per share excluding one-time items in the July-September period, down from $1.00 a year earlier. Revenue fell 19 percent to $4.53 billion.

Analysts had forecast Teva would earn 54 cents a share ex-items on revenue of $4.53 billion, according to I/B/E/S data from Refinitiv.

For the full year it raised its forecast for adjusted EPS to $2.80-$2.95 from a previous estimate of $2.55-$2.80. (Reporting by Tova Cohen Editing by Steven Scheer)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below